Fractionated intravenous administration of 90Y-labeled B72.3 GYK-DTPA immunoconjugate in beagle dogs. 1993

H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
Johns Hopkins Oncology Center, Section of Radiobiology, Baltimore, MD 21205.

B72.3, a monoclonal antibody with reactivity against human adenocarcinomas, was coupled with linker-chelator GYK-DTPA using carbohydrate mediated conjugation chemistry and radiolabeled with yttrium-90. Single and double intravenous injections of radioimmunoconjugate were compared for acute and late normal tissue toxicity in 15 beagle dogs. The second injection was given 4 or 8 days after the first. Pharmacokinetics of the radioimmunoconjugate in blood, bone marrow and urine were similar for first and second injections. Only bone marrow (acute) and liver (late) toxicity were observed. Both liver and bone marrow toxicity were decreased by fractionation of the injections. After double injections, the total equitoxic dose was 15 and 60% higher for bone marrow and liver toxicity, respectively. The mechanisms of normal tissue protection offered by fractionated radioimmunoglobulin therapy (RIT) remain to be defined. Fractionated RIT will have a better therapeutic ratio than single injection RIT, if antitumor effects appear to be less susceptible to fractionation than normal tissues.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004369 Pentetic Acid An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium. DTPA,Diethylenetriamine Pentaacetic Acid,Pentetates,Penthanil,Ca-DTPA,CaDTPA,CaNa-DTPA,Calcium Trisodium Pentetate,DETAPAC,Indium-DTPA,Mn-Dtpa,Pentacin,Pentacine,Pentaind,Pentetate Calcium Trisodium,Pentetate Zinc Trisodium,Sn-DTPA,Zinc-DTPA,Indium DTPA,Pentaacetic Acid, Diethylenetriamine,Pentetate, Calcium Trisodium,Zinc DTPA
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor

Related Publications

H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
October 1994, Clinical nuclear medicine,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
November 1991, Journal of the National Cancer Institute,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
November 1972, Health physics,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
January 2014, Molecules (Basel, Switzerland),
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
January 2009, European journal of drug metabolism and pharmacokinetics,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
January 1997, Toxicologic pathology,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
January 1992, Targeted diagnosis and therapy,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
November 2004, Acta pharmacologica Sinica,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
July 1987, Neuropharmacology,
H M Vriesendorp, and Y Shao, and J E Blum, and S M Quadri, and J R Williams
December 1987, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!